Industry Audit + Company of the Year 2008
Pharm Exec's 7th annual review of the top companies. We slice and dice the numbers to see who's the best a what. (pdf)
The New Code
Effective January 1st, sales reps will have a new standard for dealing with doctors the PhRMA way
Publish or Perish
FDAAA means that you need to register clinical trials-and not only for publication planning
How Do You Solve a Problem Like Manufacturing?
Outsourcing saves money-except when it doesn't. Here's how to decide what to do.
Foreign Affairs
FDA missteps and global outsourcing are drawing Congressional scrutiny and prompting new oversight approaches
Tapping the Fount
Leaders don't always manage to do the right thing, but they constantly strive to access the wellspring of integrity within them
The M&A Numbers
Young & Partners crunches pharma's filings for, the first half of '08. The results? Ask the Japanese
The Salesforce Software Shift
The smart way to CRM is through SaaS
Attack of the Junk
The United States makes the best medicines in the world. In days to come, that could be a problem.
Unleash the Dragon 2
Concerns over quality? It's not stopping Big Pharma outsourcing and venture capital.
Place Your Bets
The industry is a-changing. Here are eight seminal events that describe how.
The Orphan Opportunity
The Orphan Drug Act was passed 25 years ago. But the challenge of actually getting rare disease drugs and therapies to patients still remains
Considering Consumer Change: Q&A with Jim Joseph, Saatchi & Saatchi
How will pharma fare in the new age of health and wellness marketing?
Doing More With Less
In order to take a big step forward, GSK looks to employ smaller licensing deals and business units
